Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xifeng Lu

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Drug Delivery|December 5, 2013
Development and evaluation of a dry powder formulation of liposome-encapsulated oseltamivir phosphate for inhalationYue Tang, Heyang Zhang, Xifeng Lu, et al.
American Journal of Physiology. Renal Physiology|May 24, 2013
(Pro)renin receptor is required for prorenin-dependent and -independent regulation of vacuolar H⁺-ATPase activity in MDCK.C11 collecting duct cellsXifeng Lu, Ingrid M Garrelds, Carsten A Wagner, et al.
Nature Reviews. Nephrology|September 19, 2017
CD36 in chronic kidney disease: novel insights and therapeutic opportunitiesXiaochun Yang, Daryl M Okamura, Xifeng Lu, et al.
Hypertension (Dallas, Tex. : 1979)|October 26, 2011
Renin- and prorenin-induced effects in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor: does (pro)renin-(pro)renin receptor interaction actually occur?Wendy W Batenburg, Xifeng Lu, Frank Leijten, et al.
Journal of Hypertension|June 8, 2013
Urinary renin and angiotensinogen in type 2 diabetes: added value beyond urinary albumin?Frederik Persson, Xifeng Lu, Peter Rossing, et al.
Advanced Healthcare Materials|April 11, 2019
Acid-Responsive H<sub>2</sub> -Releasing 2D MgB<sub>2</sub> Nanosheet for Therapeutic Synergy and Side Effect Attenuation of Gastric Cancer ChemotherapyMingjian Fan, Yanyuan Wen, Dien Ye, et al.
International Journal of Molecular Sciences|July 24, 2021
Megalin, Proton Pump Inhibitors and the Renin-Angiotensin System in Healthy and Pre-Eclamptic PlacentasYuan Sun, Lunbo Tan, Rugina I Neuman, et al.
Metallomics : Integrated Biometal Science|June 27, 2013
Metallomics for drug development: an integrated CE-ICP-MS and ICP-MS approach reveals the speciation changes for an investigational ruthenium(III) drug bound to holo-transferrin in simulated cancer cytosolSvetlana S Aleksenko, Magdalena Matczuk, Xifeng Lu, et al.
Nature Communications|October 14, 2018
Local generation of hydrogen for enhanced photothermal therapyPenghe Zhao, Zhaokui Jin, Qian Chen, et al.
Journal of Hypertension|March 19, 2014
Renin inhibitor VTP-27999 differs from aliskiren: focus on their intracellular accumulation and the (pro)renin receptorXifeng Lu, Manne Krop, Wendy W Batenburg, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Drug Delivery|December 5, 2013
Development and evaluation of a dry powder formulation of liposome-encapsulated oseltamivir phosphate for inhalationYue Tang, Heyang Zhang, Xifeng Lu, et al.
American Journal of Physiology. Renal Physiology|May 24, 2013
(Pro)renin receptor is required for prorenin-dependent and -independent regulation of vacuolar H⁺-ATPase activity in MDCK.C11 collecting duct cellsXifeng Lu, Ingrid M Garrelds, Carsten A Wagner, et al.
Nature Reviews. Nephrology|September 19, 2017
CD36 in chronic kidney disease: novel insights and therapeutic opportunitiesXiaochun Yang, Daryl M Okamura, Xifeng Lu, et al.
Hypertension (Dallas, Tex. : 1979)|October 26, 2011
Renin- and prorenin-induced effects in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor: does (pro)renin-(pro)renin receptor interaction actually occur?Wendy W Batenburg, Xifeng Lu, Frank Leijten, et al.
Journal of Hypertension|June 8, 2013
Urinary renin and angiotensinogen in type 2 diabetes: added value beyond urinary albumin?Frederik Persson, Xifeng Lu, Peter Rossing, et al.
Advanced Healthcare Materials|April 11, 2019
Acid-Responsive H<sub>2</sub> -Releasing 2D MgB<sub>2</sub> Nanosheet for Therapeutic Synergy and Side Effect Attenuation of Gastric Cancer ChemotherapyMingjian Fan, Yanyuan Wen, Dien Ye, et al.
International Journal of Molecular Sciences|July 24, 2021
Megalin, Proton Pump Inhibitors and the Renin-Angiotensin System in Healthy and Pre-Eclamptic PlacentasYuan Sun, Lunbo Tan, Rugina I Neuman, et al.
Metallomics : Integrated Biometal Science|June 27, 2013
Metallomics for drug development: an integrated CE-ICP-MS and ICP-MS approach reveals the speciation changes for an investigational ruthenium(III) drug bound to holo-transferrin in simulated cancer cytosolSvetlana S Aleksenko, Magdalena Matczuk, Xifeng Lu, et al.
Nature Communications|October 14, 2018
Local generation of hydrogen for enhanced photothermal therapyPenghe Zhao, Zhaokui Jin, Qian Chen, et al.
Journal of Hypertension|March 19, 2014
Renin inhibitor VTP-27999 differs from aliskiren: focus on their intracellular accumulation and the (pro)renin receptorXifeng Lu, Manne Krop, Wendy W Batenburg, et al.
Pageof 6